Metagen Therapeutics, Inc.
Advancement of drug discovery and development for intestinal microbiome-based therapeutics
Metagen Therapeutics, Inc., is a biotech startup founded through collaborations with Juntendo University, Keio University, and Tokyo University of Science. The company is dedicated to creating meaningful social impact through medicine and drug discovery rooted in gut microbiota research, guided by its mission : “living up to the hopes of patients through microbiome science.”
Leveraging its proprietary Gut Microbiome Bank as a core resource, Metagen Therapeutics operates both a Medical Service Business and a Drug Discovery Business to advance Fecal Microbiota Transplantation (FMT) as a global standard treatment. The company is currently focused on developing therapies for immune diseases (such as inflammatory bowel disease), cancer, and central nervous system disorders.
246-2 Mizukami, Kakuganji, Tsuruoka-city, Yamagata 997-0052 Japan
JSR Corporation
Healthcare
- Research and Development Support
- Drug Discovery/Drug Discovery Support
- Analysis
